Exec Chat: Outset Medical CEO Shares Lessons Learned On Road To Transforming Kidney Care
Medtech Insight spoke with Outset Medical’s CEO Leslie Trigg about lessons learned in her career growing medtechs and her plans for growing Tablo hemodialysis for acute and home care.
You may also be interested in...
Harbinger Health has raised a total of $190m since its founding in 2021. Its CEO Stephen Hahn told Medtech Insight in March that the company plans to develop a blood-based cancer test that is affordable, accessible and also more accurate than currently available tests.
Theradaptive Receives $7.4M From DoD, Advances Human Trials With ‘Paint-Like’ Regenerative Therapeutic
Theradaptive will use the new DoD funding to move its technology for healing bones and tissues into first human trials.
News We're Watching: Studies Back Nevro Pain Treatment, FTC Blesses Resonetics Nitinol Deal, Genetic Test Identifies Best RDN Patients
This week, studies supported Nevro’s spinal cord stimulation therapy and a VRx system that helps reduce pain; the American Medical Association found inconsistent insurance coverage of digital therapeutics; and Geneticure announced a cheek-swab test to identify which patients are most likely to benefit from renal denervation.